Related Experiment Video
Updated: Aug 3, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis
Mohamed El-Tanani1, Hamdi Nsairat2, Alaa A Aljabali3
1Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, United Kingdom.
Abstract:
The signalling system known as mammalian target of rapamycin (mTOR) is believed to be required for several biological activities involving cell proliferation. The serine-threonine kinase identified as mTOR recognises PI3K-AKT stress signals. It is well established in the scientific literature that the deregulation of the mTOR pathway plays a crucial role in cancer growth and advancement. This review focuses on the normal functions of mTOR as well as its abnormal roles in cancer development.
Insights
The mammalian target of rapamycin (mTOR) pathway regulates cell proliferation. Deregulation of this crucial signaling pathway is linked to cancer growth and progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The mammalian target of rapamycin (mTOR) is a key signaling pathway involved in regulating cell proliferation and growth.
- mTOR integrates signals from growth factors, nutrients, and cellular stress.
- Aberrant mTOR signaling is implicated in various human diseases, particularly cancer.
Purpose of the Study:
- To review the normal physiological functions of the mTOR pathway.
- To elucidate the role of mTOR deregulation in cancer development and progression.
- To provide a comprehensive overview of mTOR signaling in both normal and cancerous states.
Main Methods:
- Literature review of existing scientific publications.
- Analysis of studies investigating mTOR pathway components and functions.
- Synthesis of information on mTOR's role in cell proliferation and cancer.
Main Results:
- mTOR is essential for normal cellular processes, including protein synthesis, cell growth, and metabolism.
- Dysregulation of the mTOR pathway, including hyperactivation, is frequently observed in diverse types of cancer.
- The PI3K-AKT pathway is a major upstream regulator of mTOR activity, responding to various stress signals.
Conclusions:
- The mTOR pathway is a critical regulator of cell proliferation with vital roles in normal physiology.
- Aberrant mTOR signaling is a significant driver of tumorigenesis and cancer progression.
- Targeting the mTOR pathway presents a promising therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
MAPK Signaling Cascades
Abnormal Proliferation

